Literature DB >> 912109

Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.

A Girolami, R Dal Bo Zanon, A Sticchi.   

Abstract

At equivalent Thrombotest basal values on undiluted non-contacted plasma, there is no difference between coumarin plasma and liver damage plasma in the dilution curve system. A hemophilia BM plasma with longer basal clotting times yielded a much flatter curve and a very large "inhibitory" effect (greater than 6 Units). A coumarin plasma with the same basal Thrombotest clotting times as Hemophilia BM plasma, namely 100 seconds, yielded a much steeper curve and a very low inhibition (0.7 Units). These findings are against the presence of inhibitors in coumarin or liver damage plasmas.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912109     DOI: 10.1007/bf00999466

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  20 in total

1.  Vitamin K and the biosynthesis of prothrombin. I. Identification and purification of a dicoumarol-induced abnormal prothrombin from bovine plasma.

Authors:  J Stenflo; P O Ganrot
Journal:  J Biol Chem       Date:  1972-12-25       Impact factor: 5.157

2.  Plasma prothrombin during treatment with Dicumarol. II. Demonstration of an abnormal prothrombin fraction.

Authors:  P O Ganrot; J E Niléhn
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  Kinetic aspects of the interaction of blood clotting enzymes. 3. Demonstration of an inhibitor of prothrombin conversion in vitamin K deficiency.

Authors:  H C Hemker; J J Veltkamp; E A Loeliger
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31

4.  Lack of PIVKA effect in the abnormal factor X (factor X Friuli) coagulation disorder.

Authors:  A Girolami; A D Muller; H C Hemker
Journal:  Haemostasis       Date:  1972

5.  [Various molecular states of factor II (prothrombin). Their study by means of staphylocoagulase and anti-factor II antibodies. I. Factor II in patients treated with vitamin K antagonists].

Authors:  F Josso; J M Lavergne; M Gouault; O Prou-Wartelle; J P Soulier
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

6.  Kinetic aspects of the interaction of blood-clotting enzymes. VI. Localization of the site of blood-coagulation inhibition by the protein induced by vitamin K absence (PIVKA).

Authors:  H C Hemker; A D Muller
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

7.  Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency.

Authors:  S H Goodnight; D I Feinstein; B Osterud; S I Rapaport
Journal:  Blood       Date:  1971-07       Impact factor: 22.113

8.  Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.

Authors:  A Girolami; A Brunetti; G M Patrassi
Journal:  Am J Clin Pathol       Date:  1977-01       Impact factor: 2.493

9.  Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.

Authors:  A Girolami; G Patrassi; F Fabris
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1977

10.  Dilution curves studies in coumarin plasmas and in artificially depleted abnormal control plasmas.

Authors:  A Girolami; A Brunetti; G Patrassi
Journal:  Blut       Date:  1974-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.